{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:06:10Z","timestamp":1790143570766,"version":"4.0.1"},"reference-count":177,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.clinthera.2009.01.009","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T14:52:38Z","timestamp":1235487158000},"page":"1-31","source":"Crossref","is-referenced-by-count":110,"title":["Drug treatment of paraphilic and nonparaphilic sexual disorders"],"prefix":"10.1016","volume":"31","author":[{"given":"David R.P.","family":"Guay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.01.009_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision","year":"2000"},{"key":"10.1016\/j.clinthera.2009.01.009_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1022099026059","article-title":"The paraphilias, obsessive compulsive spectrum disorder, and the treatment of sexually deviant behavior","volume":"70","author":"Bradford","year":"1999","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.clinthera.2009.01.009_bib3_1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4065\/82.4.457","article-title":"A profile of pedophilia: Definition, characteristics of offenders, recidivism, treatment outcomes, and forensic issues","volume":"82","author":"Hall","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2009.01.009_bib3_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4065\/82.4.457","article-title":"A profile of pedophilia: Definition, characteristics of offenders, recidivism, treatment outcomes, and forensic issues","volume":"82","author":"Hall","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2009.01.009_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/070674370104600104","article-title":"The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour","volume":"46","author":"Bradford","year":"2001","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.beem.2007.04.006","article-title":"The neurophysiology of sexual arousal","volume":"21","author":"Schober","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2009.01.009_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.2003.tb07295.x","article-title":"The monoamine hypothesis for the pathophysiology of paraphihc disorders: An update","volume":"989","author":"Kafka","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinthera.2009.01.009_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cbm.687","article-title":"The treatment of paraphilias: An historical perspective","volume":"18","author":"Gordon","year":"2008","journal-title":"Crim Behav Ment Health"},{"key":"10.1016\/j.clinthera.2009.01.009_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0009922807301483","article-title":"Review of medical reports on pedophilia","volume":"46","author":"Hughes","year":"2007","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.clinthera.2009.01.009_bib9","first-page":"16","article-title":"The impact of surgical castration on sexual recidivism risk among sexually violent predatory offenders","volume":"33","author":"Weinberger","year":"2005","journal-title":"J Am Acad Psychiatry Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib10","first-page":"317","article-title":"Never going home: Does it make it safer? Does it make sense? Sex offenders, residency restrictions, and reforming risk management law","volume":"97","author":"Durhng","year":"2006","journal-title":"J Crim Law Criminol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib11","article-title":"Psychological interventions for those who have sexually offended or are at risk of offending","author":"Kenworthy","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2009.01.009_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/13668250701402767","article-title":"Comparing sexual offender treatment efficacy: Mainstream sexual offenders and sexual offenders with special needs","volume":"32","author":"Keeling","year":"2007","journal-title":"J Intellect Dev Disabil"},{"key":"10.1016\/j.clinthera.2009.01.009_bib13","first-page":"1","article-title":"Exhibitionism treated with clomipramine","volume":"150","author":"Torres","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib14","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1176\/ajp.150.8.1273b","article-title":"Exhibitionism treated with clomipramine","volume":"150","author":"Casals-Anet","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1176\/ajp.149.6.843a","article-title":"Clomipramine and a case of exhibitionism","volume":"149","author":"Wawrose","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1192\/bjp.158.6.844","article-title":"Successful treatment of paraphihc coercive disorder (a rapist) with fluoxetine hydrochloride","volume":"158","author":"Kafka","year":"1991","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib17","first-page":"169","article-title":"Three cases of paraphilias responsive to fluoxetine treatment","volume":"52","author":"Perilstein","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib18","first-page":"41","article-title":"Fluoxetine treatment of a fetish","volume":"52","author":"Lorefice","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/070674379103600233","article-title":"Tourette syndrome and recurrent paraphihc masturbatory fantasy","volume":"36","author":"Kerbeshian","year":"1991","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib20","first-page":"566","article-title":"Cross-dressing successfully treated with fluoxetine","volume":"90","author":"Jorgensen","year":"1990","journal-title":"NY State J Med"},{"key":"10.1016\/j.clinthera.2009.01.009_bib21","doi-asserted-by":"crossref","first-page":"195197","DOI":"10.1089\/cap.1998.8.195","article-title":"An adolescent male with multiple paraphilias successfully treated with fluoxetine","volume":"8","author":"Galli","year":"1998","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1176\/ajp.147.8.1089c","article-title":"Fluoxetine treatment of exhibitionism","volume":"147","author":"Bianchi","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib23","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/ajp.148.7.950a","article-title":"Fluoxetine treatment of voyeurism","volume":"148","author":"Emmanuel","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0005-7916(79)90002-8","article-title":"The effect of assertiveness training, Provera, and sex of therapist in the treatment of genital exhibitionism","volume":"10","author":"Langevin","year":"1979","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib25","first-page":"92","article-title":"Successful treatment of transvestic fetishism with sertraline and lithium","volume":"57","author":"Rubenstein","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/070674379504000103","article-title":"A treatment for impulse control disorders and paraphilia: A case report","volume":"40","author":"Bradford","year":"1995","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib27","first-page":"216","article-title":"Phenelzine and sexuality","volume":"55","author":"Warneke","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/cap.2007.0014","article-title":"Mirtazapine treatment in a subject with autistic disorder and fetishism","volume":"18","author":"Coskun","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00004850-200607000-00007","article-title":"Treatment of paraphilic sexual disorder: The use of topiramate in fetishism","volume":"21","author":"Shiah","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2190\/5UKU-NJKT-75JV-PKAB","article-title":"The use of carbamazepine for the treatment of paraphilias in a brain damaged patient","volume":"12","author":"Goldberg","year":"1982","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.clinthera.2009.01.009_bib31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1176\/appi.ajp.159.7.1245-a","article-title":"Pedophilia treated with carbamazepine and clonazepam","volume":"159","author":"Varela","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib32","first-page":"408","article-title":"Buspirone hydrochloride in the treatment of transvestic fetishism","volume":"49","author":"Fedoroff","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF01542028","article-title":"Buspirone hydrochloride in the treatment of an atypical paraphilia","volume":"21","author":"Fedoroff","year":"1992","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00005053-197509000-00009","article-title":"Successful lithium treatment of transvestism associated with manic-depression","volume":"161","author":"Ward","year":"1975","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.clinthera.2009.01.009_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1176\/appi.psychotherapy.1989.43.2.277","article-title":"Use of lithium carbonate in the treatment of autoerotic asphyxia","volume":"43","author":"Cesnik","year":"1989","journal-title":"Am J Psychother"},{"key":"10.1016\/j.clinthera.2009.01.009_bib36","first-page":"419","article-title":"Role of serotonin in forensic psychiatry","volume":"24","author":"Buckley","year":"1996","journal-title":"Bull Am Acad Psychiatry Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00207458808985786","article-title":"Naltrexone suppresses abnormal sexual behavior in Tourette's syndrome","volume":"43","author":"Sandyk","year":"1988","journal-title":"Int J Neurosa"},{"key":"10.1016\/j.clinthera.2009.01.009_bib38","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/j.1440-1614.2000.0822l.x","article-title":"Cyproterone for hypersexuality in a psychotic patient with Wilson's disease","volume":"34","author":"Volpe","year":"2000","journal-title":"Aust NZJ Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib39","first-page":"162","article-title":"Cyproteronacetate in the therapy of sexual deviations","volume":"21","author":"Zbytovsk\u00fd","year":"1979","journal-title":"Act Nerv Super (Praha)"},{"key":"10.1016\/j.clinthera.2009.01.009_bib40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1176\/ajp.145.8.1037a","article-title":"Female hypersexuality treated with cyproterone acetate","volume":"145","author":"Mellor","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/bjp.120.554.59","article-title":"Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality","volume":"120","author":"Cooper","year":"1972","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/00926239208412854","article-title":"The long-term use of cyproterone acetate in pedophilia: A case study","volume":"18","author":"Cooper","year":"1992","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.clinthera.2009.01.009_bib43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/026990598122269","article-title":"Medroxyprogesterone in the treatment of aggressive hypersexual behavior in traumatic brain injury","volume":"12","author":"Britton","year":"1998","journal-title":"Brain Inj"},{"key":"10.1016\/j.clinthera.2009.01.009_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF01541931","article-title":"Medroxyprogesterone acetate, nocturnal penile tumescence, laboratory arousal, and sexual acting out in a male with schizophrenia","volume":"19","author":"Cooper","year":"1990","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib45","first-page":"279","article-title":"Satyriasis: A case study","volume":"41","author":"Moore","year":"1980","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib46","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1176\/ajp.140.8.1036","article-title":"Medroxyprogesterone acetate antiandrogen treatment of hypersexuality in a pedophihac sex offender","volume":"140","author":"Cordoba","year":"1983","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib47","first-page":"182","article-title":"Low-dose oral medroxyprogesterone acetate in the management of the paraphilias","volume":"54","author":"Gottesman","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/07448481.1987.9939645","article-title":"Antiandrogenic treatment in a university setting","volume":"35","author":"Young","year":"1987","journal-title":"J Am Coll Health"},{"key":"10.1016\/j.clinthera.2009.01.009_bib49","first-page":"366","article-title":"A clinical trial of cyproterone acetate for sexual deviancy","volume":"85","author":"Baron","year":"1977","journal-title":"N Z Med J"},{"key":"10.1016\/j.clinthera.2009.01.009_bib50","first-page":"369","article-title":"Treatment of obsessive homosexual pedophihc fantasies with medroxyprogesterone acetate","volume":"13","author":"Pinta","year":"1978","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01102619","article-title":"Brain damage and paraphilia: Treated with medroxyprogesterone acetate","volume":"7","author":"Lehne","year":"1986","journal-title":"Sex Disabil"},{"key":"10.1016\/j.clinthera.2009.01.009_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01550364","article-title":"Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders","volume":"15","author":"Wincze","year":"1986","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib53","first-page":"19","article-title":"Medroxyprogesterone treatment for paraphihacs","volume":"23","author":"Kravitz","year":"1995","journal-title":"Bull Am Acad Psychiatry Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib54","first-page":"179","article-title":"Use of depoprovera in the treatment of aggressive sexual offenders: Preliminary report of three cases","volume":"3","author":"Barry","year":"1975","journal-title":"Bull Am Acad Psychiatry Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/070674378703200612","article-title":"Fire fetishism, diagnostic and clinical implications: A review of two cases","volume":"32","author":"Bourget","year":"1987","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib56_1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1192\/S000712500029733X","article-title":"Sadistic homosexual pedophilia treatment with cyproterone acetate","volume":"33","author":"Cooper","year":"1988","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib56_2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/070674378703200833","article-title":"Sadistic homosexual pedophilia treatment with cyproterone acetate","volume":"32","author":"Cooper","year":"1987","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib57","first-page":"249","article-title":"Depoprovera treatment for sex offending behavior: An evaluation of outcome","volume":"20","author":"Meyer","year":"1992","journal-title":"Bull Am Acad Psychiatry Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/mds.870090317","article-title":"Leuprohde acetate for exhibitionism in Huntington's disease","volume":"9","author":"Rich","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2009.01.009_bib59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/070674379003500412","article-title":"Effect of combined androgen blockade with an LH RH agonist and flutamide in one severe case of male exhibitionism","volume":"35","author":"Rousseau","year":"1990","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/00926230591006782","article-title":"A hypersexual paraphihc patient treated with leuprohde acetate: A single case report","volume":"31","author":"Saleh","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.clinthera.2009.01.009_bib61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00002826-199510000-00007","article-title":"Leuprohde treatment of sexual aggression in a patient with dementia and the Kluver-Bucy syndrome","volume":"18","author":"Ott","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/030006057400200211","article-title":"Cyproterone acetate for male hypersexuality","volume":"2","author":"Davies","year":"1974","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinthera.2009.01.009_bib63","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1520\/JFS2003035","article-title":"Treatment of paraphilia in young adults with leuprohde acetate: A preliminary case report series","volume":"49","author":"Saleh","year":"2004","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.clinthera.2009.01.009_bib64","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJM199802123380702","article-title":"Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone","volume":"338","author":"Rosier","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2009.01.009_bib65","series-title":"Presented at: The 16th Annual Research and Treatment Conference of the Association for the Treatment of Sexual Abusers","article-title":"The use of leuprohde acetate in the treatment of four types of paraphilia","author":"Gottesmann","year":"1997"},{"key":"10.1016\/j.clinthera.2009.01.009_bib66","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/070674379203700808","article-title":"The management of a case of treatment-resistant paraphilia with a long-acting LH RH agonist","volume":"37","author":"Dickey","year":"1992","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib67","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.4088\/JCP.v65n1020a","article-title":"A relapse in pedophihc sex offending and subsequent suicide attempt during luteinizing hormone-releasing hormone treatment","volume":"65","author":"Briken","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib68","first-page":"267","article-title":"Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias","volume":"53","author":"Stein","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib69","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00004583-199908000-00008","article-title":"Fluoxetine and compulsive sexual behavior","volume":"38","author":"Aguirre","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib70","first-page":"60","article-title":"Successful antidepressant treatment of nonparaphihc sexual addictions and paraphilias in men","volume":"52","author":"Kafka","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004714-199606000-00015","article-title":"Risperidone and fluoxetine in the treatment of pedophilia with comorbid dysthymia","volume":"16","author":"Bourgeois","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib72","first-page":"351","article-title":"Fluoxetine treatment of nonparaphihc sexual addictions and paraphilias in men","volume":"53","author":"Kafka","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib73","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1014795321404","article-title":"Clinical characteristics and treatment response to SSRI in a female pedophile","volume":"31","author":"Chow","year":"2002","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib74","series-title":"A Temperament Theory of Personality Development","author":"Buss","year":"1975"},{"key":"10.1016\/j.clinthera.2009.01.009_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1018737504537","article-title":"Compulsive voyeurism and exhibitionism: A clinical response to paroxetine","volume":"28","author":"Abouesh","year":"1999","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib76","first-page":"282","article-title":"Nefazodone and the treatment of nonparaphihc compulsive sexual behavior: A retrospective study","volume":"61","author":"Coleman","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib77","doi-asserted-by":"crossref","first-page":"664","DOI":"10.4088\/JCP.v61n0912","article-title":"Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphiha-related disorders: A case series","volume":"61","author":"Kafka","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib78","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4088\/JCP.v65n0715","article-title":"Naltrexone in the treatment of adolescent sexual offend- ers","volume":"65","author":"Ryback","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/009262300438797","article-title":"Use of lithium and depot neuroleptics in the treatment of paraphilias","volume":"26","author":"Zourkov\u00e1","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.clinthera.2009.01.009_bib80","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/009262300438805","article-title":"Lithium for paraphilias? Probably not","volume":"26","author":"Balon","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.clinthera.2009.01.009_bib81","first-page":"127","article-title":"Haloperidol in the therapy of severe behavior disorders","volume":"16","author":"Ban","year":"1976","journal-title":"Curr Psychiatr Ther"},{"key":"10.1016\/j.clinthera.2009.01.009_bib82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF01541489","article-title":"The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidol, chlorpromazine, and placebo","volume":"3","author":"Tennent","year":"1974","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib83","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1176\/ajp.124.7.917","article-title":"A long-acting phenothiazine as a possible agent to control deviant behavior","volume":"124","author":"Bartholomew","year":"1968","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib84","first-page":"1030","article-title":"Is benperidol the specific drug for the treatment of excessive and disinhibited sexual behavior?","volume":"66","author":"Sterkmans","year":"1966","journal-title":"Acta Neurol Psych Belg"},{"key":"10.1016\/j.clinthera.2009.01.009_bib85","first-page":"15","article-title":"Haloperidol decanoate (Janssen) in the treatment of sexual deviations","volume":"89","author":"Zbytovsk\u00fd","year":"1993","journal-title":"Cesk Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/002580247001000105","article-title":"The hormonal treatment of sexual offenders","volume":"10","author":"Field","year":"1970","journal-title":"Med Sci Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5694\/j.1326-5377.1970.tb77830.x","article-title":"Oestrogens and thrombosis","volume":"1","author":"Bartholomew","year":"1970","journal-title":"Med J Aust"},{"key":"10.1016\/j.clinthera.2009.01.009_bib88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.2.5597.83","article-title":"Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics","volume":"2","author":"Symmers","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.clinthera.2009.01.009_bib89","first-page":"225","article-title":"The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: A review","volume":"59","author":"Blackard","year":"1975","journal-title":"Cancer Chemother Rep"},{"issue":"Suppl 2A","key":"10.1016\/j.clinthera.2009.01.009_bib90","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0090-4295(01)01252-3","article-title":"The role of diethylstilbestrol in the treatment of prostate cancer","volume":"58","author":"Malkowicz","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2009.01.009_bib91_1","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-143-10-200511150-00031","article-title":"Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis","volume":"143","author":"Seidenfeld","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.009_bib91_2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.7326\/0003-4819-132-7-200004040-00009","article-title":"Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis","volume":"132","author":"Seidenfeld","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2009.01.009_bib92","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0022-5347(01)62089-5","article-title":"A phase 1\u20132 trial of diethylstilbestrol plus low dose warfarin in advanced prostate carcinoma","volume":"161","author":"Klotz","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib93","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/00365599709070324","article-title":"Treatment of high-grade, high-stage prostate cancer with estramustine phosphate or diethylstilbestrol. A double-blind study. The SPCG-1 Study Group","volume":"31","author":"Hedlund","year":"1997","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib94","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1200\/JCO.1996.14.8.2250","article-title":"Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: Fluta-mide versus diethylstilbestrol","volume":"14","author":"Chang","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib95","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.juro.2007.01.119","article-title":"Phase II study of low dose and high dose conjugated estrogen for androgen independent prostate cancer","volume":"177","author":"Pomerantz","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib96","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/bmj.293.6544.413","article-title":"Orchidectomy versus oestrogen for prostatic cancer: Cardiovascular effects","volume":"293","author":"Henriksson","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.clinthera.2009.01.009_bib97","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0022-5347(17)38385-4","article-title":"Primary orchiectomy versus estrogen therapy in advanced prostatic cancer\u2014a randomized study: Results after 7 to 10 years of followup","volume":"145","author":"Johansson","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib98_1","series-title":"Leuprolide Acetate and Tnptorelm Pamoate Monographs. AHFS Drug Information 2008","first-page":"1136","author":"Anonymous","year":"2008"},{"key":"10.1016\/j.clinthera.2009.01.009_bib98_2","series-title":"Leuprolide Acetate and Tnptorelm Pamoate Monographs. AHFS Drug Information 2008","first-page":"1257","author":"Anonymous","year":"2008"},{"key":"10.1016\/j.clinthera.2009.01.009_bib99_1","series-title":"Martindale: The Complete Drug Reference","first-page":"1644","article-title":"Cyproterone acetate, medroxyprogesterone acetate, leuprolide, triptorelin","author":"Anonymous","year":"2007"},{"key":"10.1016\/j.clinthera.2009.01.009_bib99_2","series-title":"Martindale: The Complete Drug Reference","first-page":"1657","article-title":"Cyproterone acetate, medroxyprogesterone acetate, leuprolide, triptorelin","author":"Anonymous","year":"2007"},{"key":"10.1016\/j.clinthera.2009.01.009_bib99_3","series-title":"Martindale: The Complete Drug Reference","first-page":"1904","article-title":"Cyproterone acetate, medroxyprogesterone acetate, leuprolide, triptorelin","author":"Anonymous","year":"2007"},{"key":"10.1016\/j.clinthera.2009.01.009_bib99_4","series-title":"Martindale: The Complete Drug Reference","first-page":"1920","article-title":"Cyproterone acetate, medroxyprogesterone acetate, leuprolide, triptorelin","author":"Anonymous","year":"2007"},{"key":"10.1016\/j.clinthera.2009.01.009_bib100","series-title":"Lupron (leuprohde acetate suspension for injection and depot [3.75, 7.5, 11.25, 15, 22.5, and 30 mg] injection) [package insert]","year":"2000"},{"key":"10.1016\/j.clinthera.2009.01.009_bib101","series-title":"Eligard (leuprohde acetate for injectable suspension [7.5-, 22.5-, 30-, and 45-mg depot injections]) [package insert]","year":"2006"},{"key":"10.1016\/j.clinthera.2009.01.009_bib102","series-title":"Trelstar Depot 3.75 mg and Trelstar LA (triptorelin pamoate suspension for injection) [package insert]","year":"2006"},{"key":"10.1016\/j.clinthera.2009.01.009_bib103","first-page":"1","article-title":"Triptorelin pamoate","volume":"3","author":"Anonymous","year":"1993","journal-title":"Phase III Drug Profiles"},{"key":"10.1016\/j.clinthera.2009.01.009_bib104","first-page":"262","article-title":"Monthly administration of the LH-RH analogue decapeptyl for long-term treatment of ovarian dysfunctions and estrogen-dependent disorders","volume":"34","author":"Geisthoevel","year":"1989","journal-title":"Int J Fertil"},{"key":"10.1016\/j.clinthera.2009.01.009_bib105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2125.1997.t01-1-00592.x","article-title":"Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency","volume":"44","author":"Muller","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib106","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jps.2600750211","article-title":"Single-dose pharmacokinetics of leuprohde in humans following intravenous and subcutaneous administration","volume":"75","author":"Sennello","year":"1986","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2009.01.009_bib107","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3349\/ymj.2007.48.3.421","article-title":"Incidence rate of injection-site granulomas resulting from the administration of luteinizing hormone-releasing hormone analogues for the treatment of prostatic cancer","volume":"48","author":"Shiota","year":"2007","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.clinthera.2009.01.009_bib108","doi-asserted-by":"crossref","first-page":"779.e5","DOI":"10.1016\/j.urology.2007.02.013","article-title":"Noninfective cutaneous granuloma with leuprorehn acetate\u2014reality or myth","volume":"69","author":"Dangle","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2009.01.009_bib109","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10508-005-7929-2","article-title":"Leuprohde acetate suppresses pedophihc urges and arousabihty","volume":"34","author":"Schober","year":"2005","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1010213432606","article-title":"Depot-leuprohde acetate for treatment of paraphilias: A report of twelve cases","volume":"30","author":"Krueger","year":"2001","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib111","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0447.1993.tb03402.x","article-title":"Effect of a long-lasting gonadotropin hormone-releasing hormone agonist in six cases of severe male paraphilia","volume":"87","author":"Thibaut","year":"1993","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clinthera.2009.01.009_bib112","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0306-4530(96)00004-2","article-title":"Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: A lifetime treatment?","volume":"21","author":"Thibaut","year":"1996","journal-title":"Psychoneuroendocrmology"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2009.01.009_bib113","first-page":"1","article-title":"Discovery, development, mode of action, and clinical use of cyproterone acetate","volume":"3","author":"Neumann","year":"1975","journal-title":"J Int Med Res"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2009.01.009_bib114","first-page":"10","article-title":"Steroid chemistry","volume":"3","author":"Stitch","year":"1975","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinthera.2009.01.009_bib115","first-page":"337","article-title":"Aspects of androgen-dependent events as studied by antiandrogens","volume":"26","author":"Neumann","year":"1970","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.clinthera.2009.01.009_bib116","doi-asserted-by":"crossref","first-page":"13648","DOI":"10.1074\/jbc.M611711200","article-title":"Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for hgand-mduced conformational changes and structure-based drug design","volume":"282","author":"Bohl","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinthera.2009.01.009_bib117","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0028-1094147","article-title":"The influence of antiandrogens on the excretion of FSH, LH, and 17-ketosteroids in males","volume":"3","author":"Vosbeck","year":"1971","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.clinthera.2009.01.009_bib118","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0022-4731(75)90310-6","article-title":"Antiandrogens in the treatment of sexual deviations of men","volume":"6","author":"Laschet","year":"1975","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.clinthera.2009.01.009_bib119","first-page":"1803","article-title":"Antiandrogens in the treatment of acne and hirsutism","volume":"45","author":"Jurzyk","year":"1992","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clinthera.2009.01.009_bib120","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/art.1780281108","article-title":"Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormone results with cyproterone acetate","volume":"28","author":"Jungers","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2009.01.009_bib121","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002280050340","article-title":"Investigation into the age-dependence of the pharmacokinetics of cyproterone acetate in healthy male volunteers","volume":"53","author":"Kuhnz","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib122","first-page":"412","article-title":"Radioimmunological analysis of cyproterone acetate in human serum. Comparison with a gas chromatographic\/mass spectrometric method and influence of each method on the outcome of a bioequivalence trial","volume":"46","author":"Baumann","year":"1996","journal-title":"Arzneimittel forschung"},{"key":"10.1016\/j.clinthera.2009.01.009_bib123","first-page":"555","article-title":"Pharmacokinetics of cyproterone acetate and its main metabolite 15 beta-hydroxy-cyproterone acetate in young healthy women","volume":"26","author":"Huber","year":"1988","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib124","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v59n0806e","article-title":"Irradiation therapy prevents gynecomastia in sex offenders treated with antiandrogens","volume":"59","author":"Eriksson","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1099-1557(199705)6:3<169::AID-PDS263>3.0.CO;2-3","article-title":"Safety of cyproterone acetate: Report of active surveillance","volume":"6","author":"Heinemann","year":"1997","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clinthera.2009.01.009_bib126","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1478-3231.2007.01549.x","article-title":"Suspected cross-hepatotoxicity of flutamide and cyproterone acetate","volume":"27","author":"Miquel","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.clinthera.2009.01.009_bib127","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1464-410X.2007.06859.x","article-title":"Venous thromboembolism and cyproterone acetate in men with prostate cancer: A study using the General Practice Research Database","volume":"99","author":"Seaman","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.clinthera.2009.01.009_bib128","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1520\/JFS2002089","article-title":"Osteoporosis associated with the treatment of paraphilias: A clinical review of seven case reports","volume":"48","author":"Grasswick","year":"2003","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.clinthera.2009.01.009_bib129","first-page":"39","article-title":"Cyproterone and hypersexuality","volume":"86","author":"Unger","year":"1977","journal-title":"N Z Med J"},{"key":"10.1016\/j.clinthera.2009.01.009_bib130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.1973.tb03009.x","article-title":"Reduction of sebum excretion in man by the antiandrogen, cyproterone acetate","volume":"89","author":"Burton","year":"1973","journal-title":"BrJ Dermatol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/jrf.0.0360177","article-title":"Effect of oral cyproterone acetate on urinary and serum FSH and LH levels in adult males being treated for hypersexuality","volume":"36","author":"Brotherton","year":"1974","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.clinthera.2009.01.009_bib132","first-page":"xxi","article-title":"Proceedings: Sex-hormone-binding globulin, luteinizing hormone and testosterone in man: Effects of oestrogen and cyproterone acetate","volume":"59","author":"Murray","year":"1973","journal-title":"J Endocrinol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib133","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/070674379203700108","article-title":"The effects of cyproterone acetate on sleeping and waking penile erections in pedophiles: Possible implications for treatment","volume":"37","author":"Cooper","year":"1992","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib134","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0010-440X(81)90034-1","article-title":"A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality","volume":"22","author":"Cooper","year":"1981","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib135","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/002580247001000409","article-title":"Cyproterone acetate in sexual misbehaviour","volume":"10","author":"Davies","year":"1970","journal-title":"Med Sa Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib136","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF01542555","article-title":"Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias","volume":"22","author":"Bradford","year":"1993","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib137","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF01543305","article-title":"Effects of cyproterone acetate on sexual arousal patterns of pedophiles","volume":"22","author":"Bradford","year":"1993","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib138","series-title":"Depo-subQ Provera 104 (medroxyprogesterone acetate injectable suspension 104 mg\/0.65 mL) [package insert]","year":"2004"},{"key":"10.1016\/j.clinthera.2009.01.009_bib139","series-title":"Provera (medroxyprogesterone) [package insert]","year":"1998"},{"key":"10.1016\/j.clinthera.2009.01.009_bib140","series-title":"Depo-Provera Contraceptive Injection (medroxyprogesterone acetate injectable suspension) [package insert]","year":"2004"},{"key":"10.1016\/j.clinthera.2009.01.009_bib141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00257410","article-title":"Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients","volume":"11","author":"Camaggi","year":"1983","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib142","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF01059057","article-title":"Influence of route of administration on the pharmacokinetics of methylprednisolone","volume":"11","author":"Antal","year":"1983","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.clinthera.2009.01.009_bib143","first-page":"3297","article-title":"Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate","volume":"6","author":"Kobayashi","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinthera.2009.01.009_bib144","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00292875","article-title":"The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer","volume":"8","author":"Blossey","year":"1982","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib145","first-page":"813","article-title":"Medroxyprogesterone acetate: Variation in serum concentrations achieved with three commercially available preparations","volume":"71","author":"Stockdale","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.clinthera.2009.01.009_bib146","first-page":"199","article-title":"Liver function and medroxyprogesterone acetate elimination in man","volume":"38","author":"Rautio","year":"1984","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clinthera.2009.01.009_bib147","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-199222050-00002","article-title":"Clinical pharmacokinetics of endocrine agents used in advanced breast cancer","volume":"22","author":"L\u00f8nning","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2009.01.009_bib148","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00228-006-0128-9","article-title":"Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes","volume":"62","author":"Zhang","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib149","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.contraception.2006.12.009","article-title":"Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg\/0.65 mL","volume":"75","author":"Westhoff","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.clinthera.2009.01.009_bib150","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bjo.2007.114322","article-title":"Retinal venous occlusion associated with depot medroxyprogesterone acetate","volume":"91","author":"Deen","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clinthera.2009.01.009_bib151","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2006.11.040","article-title":"Effect of depo-medroxyprogesterone acetate on coagulation parameter: A pilot study","volume":"87","author":"Goldstein","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clinthera.2009.01.009_bib152","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0015-0282(16)42857-8","article-title":"Pituitary function in adult males receiving medroxyprogesterone acetate","volume":"28","author":"Meyer","year":"1977","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clinthera.2009.01.009_bib153","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0015-0282(16)48326-3","article-title":"Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate","volume":"43","author":"Meyer","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clinthera.2009.01.009_bib154","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1210\/jcem-61-5-983","article-title":"Progesterone has no effect on serum thyroxine-binding globulin concentration in men","volume":"61","author":"Chen","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2009.01.009_bib155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF03346926","article-title":"Effect of large-dose progesterone on plasma levels of lipids, lipoproteins and apohpoproteins in males","volume":"9","author":"Chen","year":"1986","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.clinthera.2009.01.009_bib156","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1176\/ajp.138.5.644","article-title":"Treatment of sex offenders with medroxyprogesterone acetate","volume":"138","author":"Gagn\u00e9","year":"1981","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib157","first-page":"165","article-title":"The therapeutic use of androgen-depleting hormone","volume":"8","author":"Money","year":"1971","journal-title":"Int Psychiatry Clin"},{"key":"10.1016\/j.clinthera.2009.01.009_bib158","first-page":"73","article-title":"Medroxyprogesterone and paraphiles: Do testosterone levels matter","volume":"24","author":"Kravitz","year":"1996","journal-title":"Bull Am Acad Psychiatry Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib159","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1192\/bjp.125.3.310","article-title":"The control of deviant sexual behavior by drugs. I Behavioural changes following oestrogens and anti-androgens","volume":"125","author":"Bancroft","year":"1974","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib160","first-page":"163","article-title":"Comparative study of prophylactic lithium and diethylstilbestrol in sexual deviants","volume":"21","author":"B\u00e1rtov\u00e1","year":"1979","journal-title":"Act Nerv Super (Praha)"},{"key":"10.1016\/j.clinthera.2009.01.009_bib161","first-page":"72","article-title":"Pharmacological treatment of deviant sexual behavior","volume":"20","author":"B\u00e1rtov\u00e1","year":"1978","journal-title":"Act Nerv Super (Praha)"},{"key":"10.1016\/j.clinthera.2009.01.009_bib162","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/070674379203701003","article-title":"A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles","volume":"37","author":"Cooper","year":"1992","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib163","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-3223(94)90609-2","article-title":"Comparison of cyproterone acetate (CPA) and leuprohde acetate (LHRH agonist) in a chronic pedophile: A clinical case study","volume":"36","author":"Cooper","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib164","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF01542257","article-title":"Paraphilias: A double-blind crossover comparison of clomipramine versus desipramine","volume":"21","author":"Kruesi","year":"1992","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.clinthera.2009.01.009_bib165","first-page":"525","article-title":"A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: A retrospective study","volume":"24","author":"Greenberg","year":"1996","journal-title":"Bull Am Acad Psychiatry Law"},{"key":"10.1016\/j.clinthera.2009.01.009_bib166","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/107906320701900207","article-title":"The utility of the random controlled trial for evaluating sexual offender treatment: The gold standard or an inappropriate strategy","volume":"19","author":"Marshall","year":"2007","journal-title":"Sex Abuse"},{"key":"10.1016\/j.clinthera.2009.01.009_bib167","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/070674370004500608","article-title":"Protocols for the use of cyproterone, medroxyprogesterone, and leuprohde in the treatment of paraphilia","volume":"45","author":"Reilly","year":"2000","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clinthera.2009.01.009_bib168","series-title":"Twenty-Five Human Rights Documents","article-title":"United Nations. Universal declaration of human rights","year":"1994"},{"key":"10.1016\/j.clinthera.2009.01.009_bib169","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1467-8519.2008.00634.x","article-title":"Research involving prisoners: Consensus and controversies in international and European regulations","volume":"22","author":"Elger","year":"2008","journal-title":"Bioethics"},{"key":"10.1016\/j.clinthera.2009.01.009_bib170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/107906320701900302","article-title":"Human rights and the treatment of sex offenders","volume":"19","author":"Ward","year":"2007","journal-title":"Sex Abuse"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180900023X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180900023X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T02:46:42Z","timestamp":1589597202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929180900023X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":177,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S014929180900023X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.01.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}